The Role of Serology in Tracking COVID-19 Mutations
Through much of 2020, SARS-CoV-2 accumulated mutations at a slow and steady rate, but more variants have emerged with new pathogenic traits.
Read MorePosted by Chris Wolski | Jul 12, 2021 | Covid 19 |
Through much of 2020, SARS-CoV-2 accumulated mutations at a slow and steady rate, but more variants have emerged with new pathogenic traits.
Read MorePosted by Chris Wolski | Jun 24, 2021 | Company News |
A trio of cutting-edge companies have announced a collaboration that will enable nearly instant medical test results.
Read MorePosted by Melanie Hamilton-Basich | Apr 2, 2021 | Company News |
The Mayo Clinic and Thermo Fisher teams are working closely to identify candidate solutions for clinical validation and global commercialization as part of the collaboration.
Read MorePosted by Laurie Bonner | Jan 25, 2021 | Company News, Hematology & Serology |
The new agreement aims to utilize IT systems to improve clinical decision making and customer experience.
Read MorePosted by Melanie Hamilton-Basich | Jan 13, 2021 | Sequencing Systems |
Illumina Connected Analytics provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.
Read More